Full history for every metric is available with a Kvantra account
Advanced Health Intelligence Ltd (AHI.AX)
Key financial summary
Financials in AUD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | AUD m | 0 | 0 | 1 | 0 | 1 | 3 | 3 |
| Operating profit | AUD m | -4 | -3 | |||||
| Net profit | AUD m | -4 | -5 | -14 | -20 | -13 | -4 | -4 |
| EPS reported | AUD | -0.02 | -0.02 | |||||
| Operating cashflow per share | AUD | -0.02 | -0.02 | |||||
| Capex per share | AUD | 0.00 | 0.00 | |||||
| FCF per share | AUD | -0.02 | -0.02 | |||||
| Free cash flow | AUD m | -5 | -1 | |||||
| Net debt | AUD m | 2 | 2 | |||||
| Book value equity | AUD m | 2 | 2 | |||||
| Book value per share | AUD | 0.01 | 0.01 | |||||
| Number of shares | m | 254.8 | 254.8 | |||||
| DPS (TTM paid) | AUD | 0.00 | 0.00 |
Financial summary
Financials in AUD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 13.38 | 14.14 | |||||
| P/S LTM | x | 8.74 | 9.34 | |||||
| P/FCF LTM | x | -4.94 | -18.49 | |||||
| EV/EBITDA LTM | x | -8.35 | -3.17 | |||||
| EV/Sales LTM | x | 9.64 | 10.13 | |||||
| Earnings Yield LTM | % | -17.69% | -17.69% | |||||
| FCF Yield | % | -20.26% | -5.41% | |||||
| Quality | ||||||||
| ROE | % | -236.64% | -219.41% | |||||
| ROIC | % | -57.38% | -57.38% | |||||
| Operating margin | % | -137.47% | -137.47% | |||||
| Gross margin | % | -138.90% | -138.90% | |||||
| FCF/Sales | % | -177.08% | -177.08% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +309.50% | +309.50% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -1.94 | -0.55 | |||||
| Net Debt/EBITDA | x | -0.78 | -0.78 | |||||
| EBIT/Net interest | x | -5.35 | -5.35 | |||||
| Net debt/market cap | % | 9.01% | 8.53% | |||||
| Net debt/Equity | x | 1.21 | 1.21 | |||||
| Gross debt/equity | x | 1.39 | 1.39 | |||||
Company overview
Advanced Health Intelligence Ltd is an Australian company with global operations, specializing in the creation of mobile applications and technological platforms. The firm owns and patents BodyScan, its unique measurement technology that empowers users to assess their body dimensions using a smartphone. Additionally, it provides FaceScan, which is engineered for measuring vital signs and evaluating the risks associated with cardiovascular disease, heart attacks, and strokes, as well as DermaScan, a specialized dermatological scanning device. Its diverse clientele spans the mobile health and telehealth sectors, life and health insurance providers, the fitness and wellness industry, and consumer apparel companies. Formerly known as MyFiziq Limited, the company adopted the name Advanced Human Imaging Limited in March 2021. Established in 2014, its headquarters are located in South Perth, Australia.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Advanced Health Intelligence Ltd (AHI.AX)
Advanced Health Intelligence Ltd is an Australian company with global operations, specializing in the creation of mobile applications and technological platforms. The firm owns and patents BodyScan, its unique measurement technology that empowers users to assess their body dimensions using a smartphone. Additionally, it provides FaceScan, which is engineered for measuring vital signs and evaluating the risks associated with cardiovascular disease, heart attacks, and strokes, as well as DermaScan, a specialized dermatological scanning device. Its diverse clientele spans the mobile health and telehealth sectors, life and health insurance providers, the fitness and wellness industry, and consumer apparel companies. Formerly known as MyFiziq Limited, the company adopted the name Advanced Human Imaging Limited in March 2021. Established in 2014, its headquarters are located in South Perth, Australia.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free